---
title:  |
  | RSV Case Study
output: 
  bookdown::pdf_document2: 
    fig_align: center 
    fig_height: 4
    fig_width: 7
fontsize: 12pt
geometry: "left = 2cm, right = 2cm, top = 2cm, bottom = 2cm"
---

\clearpage

```{r setup, include = FALSE, warning = FALSE, message = FALSE}
knitr::opts_chunk$set(
	echo = TRUE,
	message = FALSE,
  warning = FALSE,
	fig.pos = "!htbp", 
	out.extra = ""
)

## read in the libraries

library(here)
library(kableExtra)
library(ggplot2)
library(gridExtra)
library(ValueAdapt)

## set the seed and read in the functions and simulations results

set.seed(3567256)
sims <- readRDS(here("Examples/RSV/simulations.rds"))

## colourblind friendly palette

colours <- c("#88CCEE", "#CC6677")
```

# Outline

This document contains the respiratory syncytial virus (RSV) case study presented in the *A pragmatic Bayesian adaptive trial design based on the value of information: the valueâ€driven adaptive design* manuscript. The case study is based on a proposed trial that randomises mother-infant dyads to receive either infant immunoprophylaxis (II) or maternal vaccination (MV) to prevent RSV related medical attendances (MA-RSV). It is assumed that in Australia, II is the current implemented standard practice with 100% uptake.

# Definitions

Methodological concepts are introduced in the manuscript. A summary of these defintions can be found in Table \@ref(tab:defn). 

```{r, defn, echo = FALSE}
defn <- matrix(c("$d$"                          , "A specific decision option",
                 "$\\boldsymbol{\\Theta}$"      , "Unknown parameters",
                 "$B(d, \\boldsymbol{\\Theta})$", "Benefit function",
                 "$C(d, \\boldsymbol{\\Theta})$", "Cost function",
                 "$\\lambda$"                   , "Willingness to pay parameter",
                 "$NB(d, \\boldsymbol{\\Theta}) = \\lambda \\times B(d, \\boldsymbol{\\Theta}) - C(d, \\boldsymbol{\\Theta})$"                        , "Net benefit function",
                 "$i$"                          , "A specific participant",
                 "$\\boldsymbol{x}_i$"          , "Observed data for participant $i$",
                 "$\\boldsymbol{X}_i$"          , "Yet to be observed data for participant $i$",
                 "$N$"                          , "The maximum number of participants",
                 "$j$"                          , "A specific analysis",
                 "$J$"                          , "Number of analyses", 
                 "$n_j$"                        , "Number of participants recruited between analysis $j-1$ and $j$, where $\\sum_{j=1}^J n_j = N$",
                 "$\\bar{n}_j = \\sum_{j^\\ast=1}^j n_{j^\\ast}$", "Number of participants recruited up until analysis $j$",
                 "$\\boldsymbol{x}_{1:\\bar{n}_j}$", "Observed data for analysis $j$",
                 "$\\boldsymbol{X}_{(\\bar{n}_j+1):\\bar{n}_{j+1}}$", "Yet to be observed data for the next $n_{j+1}$ participants",
                 "$\\text{EVSI}^{\\text{ }j} =  \\text{E}_{\\boldsymbol{X}_{(\\bar{n}_j+1):\\bar{n}_{j+1}} }\\left[\\underset{d}{\\text{max }} \\text{E}_{\\boldsymbol{\\Theta}|\\boldsymbol{x}_{1:\\bar{n}_j},\\boldsymbol{X}_{(\\bar{n}_j+1):\\bar{n}_{j+1}}} [NB(d,\\boldsymbol{\\Theta})]\\right] - \\underset{d}{\\text{max }} \\text{E}_{\\boldsymbol{\\Theta}|\\boldsymbol{x}_{1:\\bar{n}_j}} [NB(d,\\boldsymbol{\\Theta})]$", 
                                                  "Expected value of sample information after observing $\\bar{n}_j$ participants",
                 "$\\delta$"                    , "Fixed trial start-up cost",
                 "$\\gamma$"                    , "Trial per-participant cost"),
               nrow = 19, ncol = 2, byrow = TRUE)

kable(defn, booktabs = TRUE, caption = "Definitions.", linesep = "", escape = F) |>
  kable_styling(font_size = 7.5, latex_options = "HOLD_position") |>
  column_spec(1, width = "11cm") |>
  column_spec(2, width = "7cm")
```

\clearpage

# The net benefit function

Of interest to the policymaker is the trade-off between the difference in effectiveness of II compared to MV with respect to preventing MA-RSV in the first 12 months of life, and the respective costs of implementing each strategy. We denote the probability that infants belonging to dyads that received II or MV experience a MA-RSV within the first 12 months with $p_\text{II}$ or $p_\text{MV}$, respectively, where $\boldsymbol{\Theta} = \{p_\text{II},p_\text{MV}\}$.

We assume that in Australia there are on average 300,000 births per year, the willingness to pay to prevent each MA-RSV is $\lambda$ and that there are no other RSV related healthcare costs (i.e., we ignore costs of parental work absenteeism and potential long term respiratory consequences such as asthma). The individual costs for II and MV are \$590 and \$330, respectively. Considering a 15 year horizon with an annual discount rate of 5%, the net benefit functions in \$1 million units are:

\begin{align*}
NB(II, \boldsymbol{\Theta}) &= \frac{1}{1,000,000} \times \sum_{t=1}^{15} 1.05^{1-t} \times 300,000 \times (-\lambda \times p_\text{II} - 590) \\
NB(MV, \boldsymbol{\Theta}) &= \frac{1}{1,000,000} \times \sum_{t=1}^{15} 1.05^{1-t} \times 300,000 \times (-\lambda \times p_\text{MV} - 330)
\end{align*}

The utility function required to implement the net benefit functions are below:

```{r}
U <- function(d, Theta, lambda = 5200){
  cost <- ifelse(d == 1, 590, 330)
  1/1000000*sum(1.05^(1-(1:15)))*300000*(-lambda*Theta[,d] - cost)
}
```

We define the incremental net monetary benefit (INMB) as the difference between the net benefit functions (i.e., $INMB(\boldsymbol{\Theta}) = NB(MV, \boldsymbol{\Theta}) - NB(II, \boldsymbol{\Theta})$). Here we that MV will be more cost effective than II if $p_\text{MV} - p_\text{II} < \frac{590 - 330}{\lambda}$ (we assume that there are no costs to change the strategy from II to MV). We assume the willingness to pay parameter to be $\lambda = \$5,200$ so that MV will be the optimal decision if $p_\text{MV} - p_\text{II} < 5\%$ and II will be the optimal decision, otherwise. 

# The trial

Suppose that a potential trial comparing the strategies head-to-head aims to recruit up to a maximum of 1,000 mother-infant dyads, denoted $i_k$, randomised to each strategy $k \in \{\text{MV},\text{II}\}$ and is estimated have a fixed start-up cost ($\delta$) of \$1 million and a per-dyad cost ($\gamma$) of \$2,000. Dyad $i_k$ has outcome $x_{i_k}$, where $x_{i_k} = 1$ if the infant from dyad $i_k$ experiences a MA-RSV within the first 12 months and $x_{i_k} = 0$ otherwise. Analyses are conducted once every 250 dyads per strategy have been recruited and reached 12 months (i.e., $n_{1k} = n_{2k} = n_{3k} = n_{4k} = 500$). The following Binomial model is implemented at analysis $j$:

$$
\sum_{i_k=1}^{\bar{n}_{jk}} X_{i_k} \sim \text{Binomial}(\bar{n}_{jk}, p_k) \quad \forall k \in \{\text{MV},\text{II}\}
$$

We assume weakly informative Beta(4,20) priors for both unknown parameters $p_\text{II}$ and $p_\text{MV}$.

For a value-driven adaptive design, the trial is stopped at an analysis if the EVSI of proceeding until the next analysis (continuing the trial) is exceeded by the cost of continuing ($\gamma \times 500$).

\clearpage

# Implementation of the value-driven adaptive design

Prior to conducting the trial, we conduct a health economic analysis to determine whether or not \textit{any} data collection is cost-effective (i.e., compute $\text{EVSI}^0$). We use the regression method developed by *Strong et al. (2015)* to estimate the EVSI (note that in principle any approximation method may be used and should be chosen with the context of the application in mind).

First, we need to generate the prior distributions:

```{r}
N_draw <- 100000
prior <- matrix(c(rbeta(N_draw, 4, 20), rbeta(N_draw, 4, 20)),
                nrow = N_draw, ncol = 2, 
                dimnames = list(NULL, c("II", "MV")))
```

Given the prior distribution on the parameters, we can investigate the uncertainty in the INMB. Figure \@ref(fig:INMB-0) shows how the distribution is centered close to zero (black dashed line) and so it is unclear which strategy is more cost-effective (the expected value of the distribution shown by the red dashed line is actually positive because the prior distributions are the same for both parameters and MV is cheaper, but the high uncertainty makes this point irrelevant).

```{r, INMB-0, echo = FALSE, fig.cap = "Parameter prior distributions and the distribution of incremental net monetary benefit (INMB) prior to data collection. The black dashed line at zero represents the decision point between the maternal vaccination (MV) and infant immunoprophylaxis (II) strategies. The red dashed line represents the expected (mean) INMB."}
prior_long <- data.frame(x = as.vector(prior), Parameter = rep(c("II", "MV"), each = N_draw))
p1 <- ggplot(prior_long, aes(x = x, colour = Parameter)) +
  geom_density() +
  scale_colour_manual(values = colours, labels = expression(p[II], p[MV])) +
  xlab("Prior distribution") +
  theme(legend.position = "bottom")

INMB_0 <- U(2, prior) - U(1, prior)
p2 <- ggplot(mapping = aes(x = INMB_0)) + 
  geom_density() +
  geom_vline(aes(xintercept = 0), linetype = "dashed") +
  geom_vline(aes(xintercept = mean(INMB_0)), linetype = "dashed", colour = "#CC6677") +
  xlab("INMB prior to data collection")

grid.arrange(p1, p2, nrow = 1)
```

For later use, we define the function to generate the posterior distribution conditional on a set of observed data below:

```{r}
post_fun <- function(N_draw, x, N_prop = 250) 
  rbeta(N_draw, 4 + x, 20 + N_prop - x)
```

Before computing the EVSI we must first define the sampling and statistic functions and the non-parametric model:

```{r}
samp_fun <- function(Theta, N_prop = 250) 
  matrix(c(rbinom(nrow(Theta), size = N_prop, prob = Theta[,"II"]),
           rbinom(nrow(Theta), size = N_prop, prob = Theta[,"MV"])),
         nrow = nrow(Theta), ncol = 2, dimnames = list(NULL, c("II", "MV")))

stat_fun <- function(x) x

model <- "s(II) + s(MV)"
```

We then compute $\text{EVSI}^0$ to determine if we should proceed to the first analysis:

```{r}
EVSI_0 <- evsi(D = 2, U = U, Theta = prior, samp_fun = samp_fun,
               stat_fun = stat_fun, model = model)
EVSI_0
```

If $\text{EVSI}^0$ exceeds the cost of conducting the trial up to the first analysis then we proceed:

```{r}
delta <- 1
gamma <- 0.002
EVSI_0 > delta + gamma*500
```

The trial now starts and we simulate data for full trial ($N = 2,000$) and conduct the first analysis ($n_{1k} = 250$). The data generation relies on the "true" parameters which depend on the given scenario. Note that dyads are randomised with equal allocation (i.e., there will be $N/2$ dyads randomised to each strategy) and the simulated data is summarised as the sum of events at each analysis (i.e., $\sum_{i=1}^{\bar{n}_{jk}} x_i$).

We consider the following two scenarios: 

1) II is more effective than MV. We set $p_\text{II} = 0.10$ and $p_\text{MV} = 0.18$.
2) Both strategies have similar effectiveness. We set $p_\text{II} = p_\text{MV} = 0.10$.

\clearpage

## Scenario 1: Infant immunoprophylaxis more effective

We simulate data assuming $p_\text{II} = 0.10$ and $p_\text{MV} = 0.18$:

```{r}
dat_scen1 <- sapply(1:4, function(x)
                c("II" = rbinom(1, size = 500/2, prob = 0.10),
                  "MV" = rbinom(1, size = 500/2, prob = 0.18)))
dat_scen1 <- apply(dat_scen1, 1, cumsum)
rownames(dat_scen1) <- paste("Analysis", 1:4)
dat_scen1
```

For each analysis, we estimate the posterior distribution of the unknown parameters:

```{r}
post_scen1 <- lapply(1:4, function(i)
  matrix(c(post_fun(N_draw, x = dat_scen1[i,"II"], N_prop = 250*i),
           post_fun(N_draw, x = dat_scen1[i,"MV"], N_prop = 250*i)),
         nrow = N_draw, ncol = 2, 
         dimnames = list(NULL, c("II", "MV"))))
```

At each analysis we can see how the reduction in uncertainty in the parameters propagates through to a reduction in uncertainty in the net benefit. We visualise this in Figure \@ref(fig:INMB-1). 

```{r, INMB-1, echo = FALSE, fig.cap = "Parameter posterior distributions and the distribution of incremental net monetary benefit (INMB) at each analysis in Scenario 1. The black dashed line at zero represents the decision point between the maternal vaccination and infant immunoprophylaxis strategies. The red dashed lines represent the expected (mean) INMB."}
post_scen1_long <- data.frame(x = unlist(post_scen1),
                              Parameter = rep(rep(c("II", "MV"), each = N_draw), 4),
                              Analysis = rep(paste("Analysis", 1:4), each = N_draw*2))

p1 <- ggplot(post_scen1_long, aes(x = x, colour = Parameter)) +
  facet_grid(Analysis ~ .) +
  geom_density() +
  scale_colour_manual(values = colours, labels = expression(p[II], p[MV])) +
  xlab("Posterior distribution") +
  theme(legend.position = "bottom")

INMB_1 <- lapply(post_scen1, function(Theta) U(2, Theta) - U(1, Theta))
INMB_1 <- data.frame(x = unlist(INMB_1), 
                     E = rep(sapply(INMB_1, mean), each = N_draw),
                     Analysis = rep(paste("Analysis", 1:4), each = N_draw))

p2 <- ggplot(INMB_1, aes(x = x)) +
  facet_grid(Analysis ~ .) +
  geom_density() +
  geom_vline(aes(xintercept = 0), linetype = "dashed") +
  geom_vline(aes(xintercept = E), linetype = "dashed", colour = "#CC6677") +
  xlab("INMB")

grid.arrange(p1, p2, nrow = 1)
```

For each analysis, given the updated posterior distribution of the parameters, we compute the EVSI to determine if the trial should continue:

```{r}
EVSI_1 <- sapply(post_scen1, function(Theta) 
             evsi(D = 2, U = U, Theta = Theta,samp_fun = samp_fun,
                  stat_fun = stat_fun, model = model))
EVSI_1
```

We compare the EVSI at each analysis to the cost of continuing the trial (i.e., $\gamma \times 500$):

```{r}
EVSI_1 > gamma*500
```

\clearpage

## Scenario 2: Similar effectiveness

We simulate data assuming $p_\text{MV} = p_\text{II} = 0.10$:

```{r}
dat_scen2 <- sapply(1:4, function(i)
                c("II" = rbinom(1, size = 500/2, prob = 0.10),
                  "MV" = rbinom(1, size = 500/2, prob = 0.10)))
dat_scen2 <- apply(dat_scen2, 1, cumsum)
rownames(dat_scen2) <- paste("Analysis", 1:4)
dat_scen2
```

For each analysis, we estimate the posterior distribution of the unknown parameters:

```{r}
post_scen2 <- lapply(1:4, function(i)
  matrix(c(post_fun(N_draw, x = dat_scen2[i,"II"], N_prop = 250*i),
           post_fun(N_draw, x = dat_scen2[i,"MV"], N_prop = 250*i)),
         nrow = N_draw, ncol = 2, 
         dimnames = list(NULL, c("II", "MV"))))
```

At each analysis we can see how the reduction in uncertainty in the parameters propagates through to a reduction in uncertainty in the net benefit. We visualise this in Figure \@ref(fig:INMB-2). 

```{r, INMB-2, echo = FALSE, fig.cap = "Parameter posterior distributions and the distribution of incremental net monetary benefit (INMB) at each analysis in Scenario 2. The black dashed line at zero represents the decision point between the maternal vaccination and infant immunoprophylaxis strategies. The red dashed lines represent the expected (mean) INMB."}
post_scen2_long <- data.frame(x = unlist(post_scen2),
                              Parameter = rep(rep(c("II", "MV"), each = N_draw), 4),
                              Analysis = rep(paste("Analysis", 1:4), each = N_draw*2))

p1 <- ggplot(post_scen2_long, aes(x = x, colour = Parameter)) +
  facet_grid(Analysis ~ .) +
  geom_density() +
  scale_colour_manual(values = colours, labels = expression(p[II], p[MV])) +
  xlab("Posterior distribution") +
  theme(legend.position = "bottom")

INMB_2 <- lapply(post_scen2, function(Theta) U(2, Theta) - U(1, Theta))
INMB_2 <- data.frame(x = unlist(INMB_2), 
                     E = rep(sapply(INMB_2, mean), each = N_draw),
                     Analysis = rep(paste("Analysis", 1:4), each = N_draw))

p2 <- ggplot(INMB_2, aes(x = x)) +
  facet_grid(Analysis ~ .) +
  geom_density() +
  geom_vline(aes(xintercept = 0), linetype = "dashed") +
  geom_vline(aes(xintercept = E), linetype = "dashed", colour = "#CC6677") +
  xlab("INMB")

grid.arrange(p1, p2, nrow = 1)
```

For each analysis, given the updated posterior distribution of the parameters, we compute the EVSI to determine if the trial should continue:

```{r}
EVSI_2 <- sapply(post_scen2, function(Theta) 
             evsi(D = 2, U = U, Theta = Theta,samp_fun = samp_fun,
                  stat_fun = stat_fun, model = model))
EVSI_2
```

We compare the EVSI at each analysis to the cost of continuing the trial (i.e., $\gamma \times 500$):

```{r}
EVSI_2 > gamma*500
```

\clearpage

# Simulations

In this section we investigate the long run performance of the value-driven adaptive design for the RSV case study. We generated 10,000 simulated trials for each scenario. First, we visualise the proportion of trials that stopped due to the value of information criterion (i.e., $\text{EVSI}^j < \gamma \times 500$) in Figure \@ref(fig:evsi-prop).

```{r, evsi-prop, echo = FALSE, fig.cap = "Proportion of trials at each analysis that stopped due to the value of information criterion, by scenario."}
sims$Stop <- sims$EVSI < gamma*500
sims_summ <- sapply(unique(sims$Scenario), function(scenario) 
                sapply(unique(sims$Analysis), function(analysis) 
                   mean(sims[sims$Scenario == scenario & sims$Analysis == analysis,]$Stop)))
sims_summ <- data.frame(Prop = as.vector(sims_summ),
                        Scenario = rep(unique(sims$Scenario), each = length(unique(sims$Analysis))),
                        Analysis = rep(1:4, length(unique(sims$Scenario))))

ggplot(sims_summ, aes(x = Analysis, y = Prop, group = Scenario, colour = Scenario)) +
  geom_line() +
  scale_y_continuous("Proportion of trials stopped", limits = c(0,1)) +
  scale_colour_manual("", values = colours) +
  theme_bw() +
  theme(legend.position = "bottom")
```

Finally, the mean sample sizes under each design and scenario are:

```{r}
sims_ss <- sapply(unique(sims$Scenario), function(scenario) 
              sapply(unique(sims$Simulation), function(sim){
                 dat <- sims[sims$Scenario == scenario & sims$Simulation == sim,]
                 stop_time <- ifelse(!any(dat$Stop), 4, min(which(dat$Stop)))
                 seq(500, 2000, by = 500)[stop_time]
              }))
round(colMeans(sims_ss))
```